Abstract
HELLP syndrome is a pregnancy related disease, presenting a triad of Hemolysis, Elevated Liver enzymes, Low Platelets. This syndrome is characterized by its multisystemic affection, presenting a high maternal and fetal morbimortality. It is estimated that around 0,1-0,9% of all pregnancies are affected, primarily between the 27-37 weeks of gestation; and about 10-20% are also presented with preeclampsia. These patients usually refer epigastric pain or in the upper right quadrant of the abdomen, nausea and/or vomits, and the diagnosis is made by the triad: microangiopathic anemia, elevated liver enzymes and thrombocytopenia. After the diagnosis, it should be managed in a hospital and a multidisciplinary team because of the possible mother and fetus complications. The treatment is primarily symptomatic and to perform the delivery between 24-48 hours post diagnosis.
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The authors keep the copyright and publication rights in the journal the right of the first publication and this possibility to edit, reproduce, distribute, expose and publicly communicate on the magazine's website. Likewise, it assumes the commitment on any litigation or claim related to the rights of intellectual property, exonerating of responsibility to the Science and Health Magazine of the UCIMED. In addition, you can see how they are published in this journal (eg, Include in an institutional repository or publish it in a book) as long as they clearly indicate the work published for the first time in the magazine Science and Health of the UCIMED.